Prelude Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,000
| Closed | -$97.6K | – | 1307 |
|
|
2023
Q4 | $97.6K | Buy |
+12,000
| New | +$97.6K | 0.01% | 900 |
|
|
2023
Q2 | – | Sell |
-46,435
| Closed | -$284K | – | 1123 |
|
|
2023
Q1 | $284K | Buy |
+46,435
| New | +$284K | 0.02% | 593 |
|
|
2021
Q1 | – | Sell |
-4,481
| Closed | -$208K | – | 1240 |
|
|
2020
Q4 | $208K | Sell |
4,481
-5,325
| -54% | -$247K | 0.01% | 651 |
|
|
2020
Q3 | $323K | Sell |
9,806
-1,852
| -16% | -$61K | 0.02% | 371 |
|
|
2020
Q2 | $320K | Buy |
11,658
+3,559
| +44% | +$97.7K | 0.02% | 391 |
|
|
2020
Q1 | $242K | Sell |
8,099
-6,669
| -45% | -$199K | 0.02% | 231 |
|
|
2019
Q4 | $409K | Buy |
14,768
+75
| +0.5% | +$2.08K | 0.02% | 351 |
|
|
2019
Q3 | $267K | Buy |
14,693
+14,633
| +24,388% | +$266K | 0.01% | 387 |
|
|
2019
Q2 | $1K | Buy |
+60
| New | +$1K | ﹤0.01% | 1182 |
|
|
2018
Q4 | – | Sell |
-5,500
| Closed | -$62K | – | 1562 |
|
|
2018
Q3 | $62K | Sell |
5,500
-2,500
| -31% | -$28.2K | ﹤0.01% | 772 |
|
|
2018
Q2 | $102K | Sell |
8,000
-2,500
| -24% | -$31.9K | 0.01% | 711 |
|
|
2018
Q1 | $177K | Buy |
10,500
+500
| +5% | +$8.43K | 0.01% | 627 |
|
|
2017
Q4 | $80K | Buy |
10,000
+2,500
| +33% | +$20K | 0.01% | 748 |
|
|
2017
Q3 | $58K | Sell |
7,500
-32,034
| -81% | -$248K | 0.01% | 956 |
|
|
2017
Q2 | $291K | Sell |
39,534
-300
| -0.8% | -$2.21K | 0.03% | 417 |
|
|
2017
Q1 | $297K | Buy |
39,834
+15,116
| +61% | +$113K | 0.03% | 399 |
|
|
2016
Q4 | $172K | Buy |
24,718
+4,773
| +24% | +$33.2K | 0.02% | 603 |
|
|
2016
Q3 | $164K | Buy |
19,945
+18,945
| +1,895% | +$156K | 0.02% | 577 |
|
|
2016
Q2 | $8K | Sell |
1,000
-15,500
| -94% | -$124K | ﹤0.01% | 1353 |
|
|
2016
Q1 | $84K | Buy |
+16,500
| New | +$84K | 0.01% | 746 |
|
|
2015
Q3 | – | Sell |
-3,700
| Closed | -$34K | – | 1532 |
|
|
2015
Q2 | $34K | Buy |
3,700
+2,500
| +208% | +$23K | ﹤0.01% | 1161 |
|
|
2015
Q1 | $15K | Buy |
+1,200
| New | +$15K | ﹤0.01% | 1711 |
|